Skip to the main content

Review article

Selective Serotonin Reuptake Inhibitors

Marina Šagud
Alma Mihaljević-Peleš
Miro Jakovljević


Full text: croatian pdf 83 Kb

page 165-170

downloads: 4.612

cite


Abstract

Depression is a very frequent disease that
can be serious, and sometimes can even endanger the
patient's life. Thanks to the increase of new antidepressants
within the last 15 years, the possibilities of pharmacological
treatment of depression are broadened. Selective
serotonin reuptake inhibitors (SSRI) are today the drugs of
first choice in treating depression (1). The aims of this
review are to present similarities and differences among
SSRIs that can be of clinical importance, and to discuss the
latest data about this group of medications.

Keywords

depression; SSRI

Hrčak ID:

19966

URI

https://hrcak.srce.hr/19966

Publication date:

25.9.2002.

Article data in other languages: croatian

Visits: 6.480 *